Beginner Research Starter Pack: First Compound Selection Guide

Research Disclaimer: All compounds described are sold exclusively for in-vitro and laboratory research use. Not for unsupervised use. This content does not constitute medical advice.

Researchers new to the research compound space face the challenge of choosing from a large number of compounds without established experience. The right starting point depends on your research objective — there is no universally "best first compound" because the optimal choice is dictated by what biology you are investigating. This guide organizes entry-point compounds by research category and explains why each is a good starting point for its domain.

Choosing by Research Objective#

Objective 1: Tissue Repair and Recovery Research#

Best entry-point compound: BPC-157

Why BPC-157 is ideal for beginners in this category:

• Most published literature of any synthetic repair peptide (>100 studies across multiple tissue types)
• Simple reconstitution: dissolve in BAC water; stable for 28 days
• Forgiving research design: effects are detectable at a range of doses in rodent models
• No HPTA effects: no hormonal confounds to manage
• No aromatization: no estrogenic control required
• Well-characterized endpoints: VEGF, Egr-1, collagen, angiogenesis markers are standard molecular endpoints

Entry protocol:

• Model: rat Achilles tendon partial transection
• Compound: BPC-157 at 10 μg/kg SC once daily
• Duration: 4 weeks
• Endpoints: tensile strength, Masson trichrome histology, VEGF ELISA

Add next: TB-500 as the second compound — after understanding BPC-157's individual profile, adding TB-500 creates the recovery stack comparison.

Objective 2: Growth Hormone Axis Research#

Best entry-point compound: Ipamorelin

Why ipamorelin is ideal for GH axis beginners:

• Most selective GHSR-1a agonist: minimal off-target effects (no cortisol, prolactin, appetite stimulation at research doses)
• Short t½ (~2h): rapid, clearly defined GH pulse response makes PK-PD studies straightforward
• Simple reconstitution: BAC water; standard SC injection
• Well-characterized GH peak timing: 15–30 min post-injection → easy blood sampling protocol
• Available as oral format comparator (MK-677) when oral bioavailability is of interest

Entry protocol:

• Model: normal adult rat
• Compound: ipamorelin at 300 μg/kg SC
• Sampling: blood at t=0, 15, 30, 60, 90, 120 min
• Endpoint: serum GH (ELISA); GH AUC calculation

Add next: CJC-1295 — after characterizing ipamorelin's individual GH pulse profile, add CJC-1295 to demonstrate the GHSR-1a + GHRHR synergy.

Objective 3: Metabolic and GLP-1 Research#

Best entry-point compound: Semaglutide

Why semaglutide is ideal for metabolic research beginners:

• Most published GLP-1R agonist with established DIO mouse protocols
• Long t½ (~7 days): once-weekly dosing simplifies chronic protocols
• Extensive literature for dose reference: published rodent doses range from 10–60 nmol/kg/week
• Clear, measurable endpoints: body weight, food intake, fasting glucose, IPGTT

Entry protocol:

• Model: DIO C57BL/6J mice (12 weeks HFD)
• Compound: semaglutide 30 nmol/kg SC once weekly
• Duration: 6 weeks
• Endpoints: body weight, food intake, DEXA body composition, IPGTT at baseline and endpoint

Add next: Tirzepatide as a comparison arm — once the semaglutide-alone protocol is established, adding tirzepatide (GLP-1R + GIPR) demonstrates dual agonist advantages.

Objective 4: Androgen and AR Research#

Best entry-point compound: Testosterone Enanthate

Why testosterone enanthate is ideal for AR research beginners:

• Universal AR reference compound: every SARM, AI, PCT study references testosterone
• Enanthate ester: twice-weekly dosing frequency (practical); 4.5-day t½ allows steady-state modeling
• Complete AR + estrogen profile: aromatization provides both AR and ER endpoints simultaneously
• Most published precedent of any androgen compound

Entry protocol:

• Model: castrated male rat (eliminates endogenous testosterone as confound)
• Compound: testosterone enanthate 10 mg/kg IM twice weekly
• Duration: 8 weeks
• Endpoints: seminal vesicle weight (androgenic), levator ani muscle weight (anabolic), serum LH/FSH

Castrated rat model is standard for androgen research because:

• Endogenous testosterone is eliminated → exogenous compound produces clean, attributable effects
• Both anabolic (levator ani) and androgenic (seminal vesicle, prostate) endpoints respond predictably to AR stimulation

Essential Supplies for Any Starter Research Kit#

Regardless of which compound category you start with:

Research Use Only. JuicedPharma does not provide medical advice.

Published by JuicedPharma Research Team · October 2026 · Category: Research Protocols & Science